Regular Article
The role of HHV-8 in Kaposi's sarcoma

https://doi.org/10.1006/scbi.1999.0129Get rights and content

Abstract

The epidemiology of Kaposi's sarcoma (KS) amongst North American and Northern European patients with AIDS suggests that an infectious agent other than HIV is involved in its pathogenesis. Several lines of evidence indicate that human herpesvirus 8 (HHV–8), also termed Kaposi's sarcoma associated herpesvirus, is the sought after agent. DNA of HHV–8 is invariably found in all forms of KS where the virus is present in the KS spindle cell. In contrast, HHV–8 DNA is not regularly detected in most other malignancies. Antibodies against HHV–8 are more frequently found in groups at risk of KS, and HHV–8 seroconversion precedes KS development. Several HHV–8 genes have been identified that exhibit transforming potential in cell culture systems. In addition, the virus encodes and induces several cytokines and angiogenic factors. This is of particular interest as models of KS pathogenesis developed before the discovery of HHV-8 emphasized the importance of inflammatory cytokines. Although the expression pattern of viral genes in KS is not certain yet, it appears likely that the pathogenetic role of HHV–8 in KS may be rather complex and differs from other virus-induced malignancies.

@9cBackground: Kaposi's sarcoma among AIDS patients—evidence for a sexually transmitted infection@21K aposi's sarcoma (ks) was—and outside of the HIV-infected population still is—a rare disease in Europe and the United States. In its `classical' form it afflicts elderly men of Mediterranean or Eastern European origin, where it may progress slowly over several years. The unusual occurrence of a more aggressive variant of KS in young homosexual men was one of the first signs of the beginning of AIDS epidemic.1Out of the 90,990 persons with AIDS that were reported to the Centers for Disease Control until March 1989, 13,616 or 15% suffered from Kaposi's sarcoma.2KS was thus at least 20,000 times more common in persons with AIDS than expected in the general population. The peculiar epidemiology of KS in different HIV-transmission groups clearly indicated that an environmental or transmis- sible agent other than HIV must be involved in KS pathogenesis.2Most notably, whereas approximately 20% of homo- and bisexual AIDS-patients developed KS, only 1% of age- and sex-matched men with hemophilia suffered from this uncommon tumor (Figure 1). This triggered a broad search for behavioral factors3and infectious agents associated with increased risk for KS. Several known human viruses were identified in KS tissues by PCR, including human cytomegalovirus,4human herpesvirus 6,5human papilloma viruses 16/186and BK virus.7However, none of these factors or viruses was found to be linked consistently to KS.8–10Representational difference analysis, a PCR-based method targeted at the identification of differences between two complex genomes, was published in 1993.11Application of this technique to Kaposi's sarcoma resulted in the identification of two short DNA fragments from a new herpesvirus by Yuan Chang, Patrick Moore and their colleagues.12This virus, now termed human herpesvirus 8 (HHV-8) or Kaposi's sarcoma-associated herpesvirus (KSHV), is the first known human member of the genus Rhadinovirus or γ2-herpesviruses.<fig 1>

References (83)

  • Kien AE Friedman et al.

    Disseminated Kaposi's sarcoma in homosexual men

    Ann Intern Med

    (1982)
  • Beral, V, Peterman, TA, Berkelman, RL, Jaffe, HW, 1990, 123,...
  • B Siegal et al.

    Kaposi's sarcoma in immunosuppression. Possibly the result of a dual viral infection

    Cancer

    (1990)
  • W Kempf et al.

    [Detection of human herpesvirus type 6, human herpesvirus type 7, cytomegalovirus and human papillomavirus in cutaneous AIDS-associated Kaposi's sarcoma]

    Verh Dtsch Ges Pathol

    (1994)
  • V Adams et al.

    Detection of several types of human papilloma viruses in AIDS-associated Kaposi's sarcoma

    J Med Virol

    (1995)
  • P Monini et al.

    Latent BK virus infection and Kaposi's sarcoma pathogenesis

    Int J Cancer

    (1996)
  • Lifson, AR, Darrow, WW, Hessol, NA, O'Malley, PM, Barnhart, L, Jaffe, HW, R, utherford, GW,...
  • W Kempf et al.

    CD68+cells of monocyte/macrophage lineage in the environment of AIDS-associated and classic sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B

    Proc Natl Acad Sci USA

    (1997)
  • NA Lisitsyn et al.

    Cloning the differences betw een to complex genomes

    Science

    (1993)
  • Y Chang et al.

    Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

    Science

    (1994)
  • Neipel, F, Albrecht, JC, Ensser, A, Huang, YQ, Li, JJ, Friedman, Kien, AE, Fleckenstein, B,...
  • E Cesarman et al.

    Kaposi's sar coma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

    N Engl J Med

    (1995)
  • CS Rabkin et al.

    Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group

    J Infect Dis

    (1998)
  • SJ Gao et al.

    KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma

    Nat Med

    (1996)
  • DH Kedes et al.

    The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women

    J Am Med Assoc

    (1997)
  • G Miller et al.

    Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus inpatients with HIV-1 infection

    N Engl J Med

    (1996)
  • MS Raab et al.

    The immunogenic glycoprotein gp35–37 of human herpesvirus 8 is encoded by open reading frame K8.1

    J Virol

    (1998)
  • JN Martin et al.

    Sexual transmission and the natural history of human herpesvirus 8 infection

    N Engl J Med

    (1998)
  • K Ariyoshi et al.

    Kaposi's sarcoma in the Gambia, West Africa, is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8

    J Hum Virol

    (1998)
  • JJ Russo et al.

    Nucleotide sequence of the Kaposi's sarcoma-accociated herpesvirus (HHV-8)

    Proc Natl Acad Sci USA

    (1996)
  • H Lee et al.

    Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus

    Nat Med

    (1998)
  • H Lee et al.

    Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus

    Mol Cell Biol

    (1998)
  • T Fujita et al.

    Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-β gene regulatory elements

    EMBO J

    (1988)
  • S Itoh et al.

    Sequence of a cDNA coding for human IRF-2

    Nucleic Acids Res

    (1989)
  • H Nguyen et al.

    Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain

    Oncogene

    (1995)
  • SJ Gao et al.

    Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma

    N Engl J Med

    (1996)
  • M Li et al.

    Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor

    J Virol

    (1998)
  • JC Zimring et al.

    Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription

    J Virol

    (1998)
  • L Arvanitakis et al.

    Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation

    Nature

    (1997)
  • C Bais et al.

    G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator

    Nature

    (1998)
  • M Li et al.

    Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin

    J Virol

    (1997)
  • Cited by (59)

    • Activation and counteraction of antiviral innate immunity by KSHV: an update

      2018, Science Bulletin
      Citation Excerpt :

      Kaposi’s sarcoma-associated herpesvirus (KSHV), a γ2 herpesvirus, is etiologically associated with Kaposi’s sarcoma (KS) and two other rare lymphoproliferative disorders: a variant of multicentric Castleman disease (MCD) and primary effusion lymphoma (PEL) [1–4].

    • Kaposi sarcoma-associated herpesvirus (KSHV): Molecular biology and oncogenesis

      2010, Cancer Letters
      Citation Excerpt :

      For example, EBV is distinctly associated with Burkitt’s lymphoma, Hodgkin’s lymphoma, nasopharyngeal carcinoma, T and natural killer cells lymphoma, and post-transplant lymphoma [2–5]. KSHV is the etiological agent of several human cancers including Kaposi sarcoma (KS) [6,7], primary effusion lymphoma (PEL) [8], and the plasmablastic variant of multicentric Castleman disease (MCD) [9,10]. Additionally, there have also been reports of KSHV-associated solid lymphomas of HIV-positive and negative individuals [11] as well as KSHV-associated lymphomas in patients with primary immunodeficiencies such as common variable immunodeficiency [12].

    View all citing articles on Scopus

    Unspecified

    View full text